Globus Medical GMED
NYSE GMED
$75.11 +0.21 (+0.28%)
As of: Oct 1, 2026 · 10:33 AM EDT

Globus Medical (GMED) Short term Debt (2024)

Updated

Globus Medical (GMED) reported Short term Debt of $443.35 million for Q4 2024, up 1.4% from the prior quarter.

Analysis

Globus Medical (GMED) Short term Debt (2024) Analysis & Trends

Dating back to Q1 2024, Globus Medical's Short term Debt record includes 4 quarters.

  • Per Business Quant data, the three quarters before Q4 2024 came in at $437.14 million (Q3 2024), $430.49 million (Q2 2024) and $424.04 million (Q1 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn
10 Globus Medical 10.06 Bn 7.88 Bn 548.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 443.35 Mn
Sep 30, 2024 437.14 Mn
Jun 30, 2024 430.49 Mn
Mar 31, 2024 424.04 Mn
API Access

Globus Medical Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=GMED&period=max&api_key=YOUR_API_KEY